Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Syndax Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title |
Fee Calculation or Carry Forward Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial Effective Date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
| Feeds to be Paid | Equity | Common stock, $0.0001 par value per share | Rule 457(r) | 7,840,909(2) | $22.00 | $172,499,998 | $110.20 per $1,000,000 | $19,010 | ||||||||||||||||
| Fees Previously Paid | — | — | — | — | — | — | — | — | ||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
| Carry Forward Securities | — | — | — | — | — | — | — | — | — | |||||||||||||||
| Total Offering Amounts | $19,010(1) | |||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $19,010 | |||||||||||||||||||||||
| (1) | Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended, and relates to our Registration Statement on Form S-3ASR (File No. 333-254661). |
| (2) | Includes 1,022,727 shares of common stock issuable upon exercise of the underwriters’ option to purchase additional shares of common stock. |